TD Cowen Reiterates Buy Rating on Danaher Corporation (DHR)

Market Context

Danaher Corporation operates in the Healthcare sector. The stock currently trades at $223.23 with a market capitalization of $166.5B. The stock has declined 3.2% over the past 52 weeks.

Analyst coverage from TD Cowen provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Danaher Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Danaher Corporation

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 13, 2026	TD Cowen	Buy	N/A
Oct 13, 2026	Morgan Stanley	Overweight	N/A
Oct 07, 2026	Barclays	Overweight	N/A
Oct 05, 2026	RBC Capital	Outperform	N/A
Oct 01, 2026	Guggenheim	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View DHR Stock Page